Patents by Inventor Liran SHLUSH

Liran SHLUSH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230364062
    Abstract: A method is disclosed for treating or preventing a myeloid malignancy in a subject harboring a mutation in SRSF2 comprising: (a) analyzing in a sample of the subject for the presence of an SRSF2 mutation; and (b) administering to the subject a therapeutically effective amount of a Rho Kinase inhibitor, or an inhibitor of a downstream effector thereof, upon identification of SRSF2 mutation.
    Type: Application
    Filed: April 13, 2023
    Publication date: November 16, 2023
    Applicant: Yeda Research and Development Co. Ltd.
    Inventors: Liran SHLUSH, Tom FLEISCHER, Benjamin GEIGER, Minhua SU
  • Publication number: 20210251955
    Abstract: A method of preventing a hematopoietic disorder or malignancy in a high risk subject, the subject being positive for one or more mutation in a splicing factor, is disclosed. The method comprising administering to the subject an agent capable of inhibiting spliceosomal activity, with the proviso that said agent does not inhibit RBM39 activity.
    Type: Application
    Filed: April 28, 2021
    Publication date: August 19, 2021
    Applicants: Yeda Research and Development Co. Ltd., Memorial Sloan Kettering Cancer Center
    Inventors: Liran SHLUSH, Omar ABDEL-WAHAB